Aplastic Anaemia: Experience with Management in a Resource Limited Setting

Main Article Content

I. O. George
G. K. Eke
C. Okechukwu

Abstract

Background: Aplastic anaemia is syndrome of bone marrow failure characterized by peripheral pancytopenia and loss of haemopoietic stem cells in the bone marrow. It is a relatively rare disease with high risk of death if untreated.

Objective: To evaluate the incidence, management and outcome of aplastic anaemia in children, over a four-year period, at the University of Port Harcourt Teaching Hospital(UPTH), Nigeria.

Subjects and Methods: This was a retrospective study of case notes of all children with anaemia and bone marrow aspiration reports suggestive of aplastic anaemia in the Haematology and Oncology Units of the Department of Paediatrics, UPTH, from 1st January 2015 to 31stDecember 2018.Data retrieved included bio data, clinical and laboratory profile, and outcome. Data entry and analysis were done using the Statistical Package for Social Sciences (SPSS) version 22. Data analysis were done using descriptive statistics (proportions and frequencies) and presented in prose and frequency tables. Mean and standard deviations of quantitative data were obtained.

Results: A total of six children were treated for a plastic anaemia during the period under review, giving an annual incidence of 0.0049 cases per year. Their ages ranged from 3 to 11 years (mean 8.2±3.7), with a male to female ratio of 2:1.At presentation, they had a mean (±SD) packed cell volume of 15± 3.2%, white cell count of 2.72± 0.76x 109/L, Absolute neutrophil count (ANC) of 0.25± 0.17 x 109/L, and platelets count of 17.33± 21.36 x 109/L. They all (100%) had severe aplastic anaemia at diagnosis. Among others, they received transfusion support with unbanked fresh whole blood, platelet concentrates, antibiotics, antifungal and antiviral, oral cyclosporine and intravenous methyl-prednisolone. They were all blood transfusion dependent. The mean survival from diagnosis was 7.3± 3.08 months.

None of the patients benefited from bone marrow transplantation and anti-thymocyte immunoglobulin. Mortality rate was 83.3% and major cause of death was sepsis with thrombocytopaenic bleeding.

Conclusion: Aplastic anaemia is rare with short survival rate. There is need for the Federal Government to ensure that bone marrow/stem cell transplantation centres are available and accessible across the country, and to make drugs such as cyclosporine and anti-thymocyte immunoglobulin affordable to ameliorate the condition.

Keywords:
Aplastic anaemia, children, Port Harcourt, Nigeria.

Article Details

How to Cite
George, I. O., Eke, G. K., & Okechukwu, C. (2020). Aplastic Anaemia: Experience with Management in a Resource Limited Setting. Asian Hematology Research Journal, 3(2), 1-6. Retrieved from https://journalahrj.com/index.php/AHRJ/article/view/30126
Section
Original Research Article

References

DeZern AE, Guinan EC. Aplastic anemia in adolescents and young adults. Acta Haematol. 2014;132(3-4):331–9.

Young NS, Kaufman DW. The epidemiology of acquired aplastic anemia. Haematologica. 2008;93(4):489–92.

Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Leaverton PE, Shapiro S, et al. The epidemiology of aplastic anemia in Thailand. Blood. 2006;107(4):1299– 307.

Ehsan A, Shah SA, Ibrahim T. Epidemiology of acquired aplastic anaemia in Pakistan. J Ayub Med Coll Abbottabad. 2011;23(1):102- 105.

IAAS. Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study. Blood. 1987;70(6):1718–1721.

Bacigalupo A, Brand R, Oneto R, Bruno B, Socie G, Passweg J, et al. Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy: The European Group for Blood and Marrow Transplantation experience. Sem Hematol. 2000;37:69-80.

Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon Smith EC, Gale RP, et al. Severe aplastic anemia: A prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976;48:63-69.

Krista V, Magnus G, Kristina C, Cecilia I, Stig L, Anna S et al.Incidence and outcome of acquired aplastic anemia: Real-world data from patients diagnosed in Sweden from 2000–2011. Haematologica. 2017; 102(10):1683–1690.

Mary JY, Baumelou E, Guiguet M. Epidemiology of aplastic anemia in France: A prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood. 1990;75(8):1646–1653.

Szklo M, Sensenbrenner L, Markowitz J, Weida S, Warm S, Linet M. Incidence of aplastic anemia in metropolitan Baltimore: A population-based study. Blood. 1985; 66(1):115–119.

Montané E, Ibáñez L, Vidal X, Ballarin E, Puig R, García N et al. Epidemiology of aplastic anemia: A prospective multicenter study. Haematologica. 2008;93(4):518–523.

Arewa OP, Akinola NO. Survival in primary a plastic anaemia; experience with 20 cases from a tertiary hospital in Nigeria. Afr Health Sci. 2009;9(4):290–293.

Shin SH, Lee SE, Lee JW. Recent advances in treatment of aplastic anemia. Korean J Intern Med. 2014;29(6): 713- 26.